IBM Commits More Than $10 Billion to Quantum Computing, Funding Its Roadmap from Today's Leading Systems to the World's First Fault-Tolerant Quantum Computers
Five-year investment spans research and development, manufacturing, M&A and ecosystem expansion as…
Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases
Civorebrutinib is an investigational oral, covalent reversible BTK inhibitor designed to provide…